The mission of Oncology Advanced Practice Provider (APP) Grand Rounds is to provide a forum for high-quality oncology-based content.
This monthly series shares expertise and creates a structured network for our vast community by promoting professional development, creating opportunities for collaboration, and using evidence-based education to increase knowledge and skills to foster ongoing quality patient care
Live Webinars Self-Paced Online Courses
Receive FREE Continuing Education Credits
CME • NCPD/CNE
Upcoming Live Course
Advanced Practice Provider CME • NCPD/CNE Live Webinar |
Advanced Practice Provider CME • NCPD/CNE Live Webinar |
Self-Paced Courses, Online Courses
Advanced Practice Provider NCPD/CNE • ACPE Available August 14, 2024 – August 13, 2026 Strategies for Managing Toxicities of Oral Oncolytics Kevin Chen, PharmD, MS Aimee Faso, PharmD, BCOP, CPP Bianka Patel, PharmD, BCOP, CPP Oral oncolytics have revolutionized cancer care over the last two decades. Although they provide a more convenient & often more tolerable alternative to traditional chemotherapy agents, their unique mechanisms of action lead to a wide range of potential side effects. In this CPP panel discussion, Aimee Faso, Bianka Patel, and Kevin Chen will discuss the considerations when managing side effects for patients receiving oral oncolytic treatments for various solid tumor and hematologic malignancies. |
Advanced Practice Provider NCPD/CNE Available August 8, 2024 – August 7, 2024 Anemia and Thrombocytopenia Basics Nancy Vogler, AGPCNP-BC Nancy Vogler, AGPCNP-BC, will discuss the common types of anemia and thrombocytopenia, common causes of each, how the non-hematology provider can best manage patients with anemia and/or thrombocytopenia, and when to refer to hematology. |
Advanced Practice Provider NCPD/CNE Available June 18, 2024 – June 17, 2026 Using Acceptance and Commitment Therapy (ACT) to Help Cancer Survivors Move Forward After Treatment Melissa Holt, DNP, PMHNP-BC Lisa Kanser, PsyD Cancer survivors may face many unique psychosocial challenges. Acceptance and Commitment Therapy (ACT) is an evidence-based psychotherapeutic approach that can effectively teach patients skills to manage these challenges after completing cancer treatment. We will take you through case vignettes to show you how ACT can be applied to this patient population. |
Advanced Practice Provider NCPD/CNE Available April 19, 2024 – April 18, 2026 Physical Therapy Approaches to Oncology Care: Beyond Lymphedema Sarah Richardson, PT, DPT, CLT, WCS Tailored for medical providers, this session led by a physical therapist addresses challenges like speech and swallowing difficulties or pelvic floor issues in gynecological cancer. Explore the pivotal role of physical therapy in survivorship care plans and delve into current research supporting interventions for head and neck, gynecological, breast cancer, and other oncological conditions. Emphasizing interdisciplinary collaboration, we'll discuss the synergy between medical providers and physical therapists in delivering optimal cancer care. Additionally, learn the art of patient education in oncology rehabilitation, empowering medical providers to effectively communicate the role of physical therapy in cancer care. |
Advanced Practice Provider NCPD/CNE Available April 19, 2024 – April 18, 2026 Integrating Germline Pharmacogenomic Testing into Oncology Care Amber Cipriani, PharmD, BCOP Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice. |
Advanced Practice Provider NCPD/CNE Available February 26, 2024 – February 25, 2026 Let’s Take a BiTE Out of CRS and Neurotoxicity Bejal Kikani, MSN, FNP-BC, WHNP-BC Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities. |
Advanced Practice Provider NCPD/CNE Available February 23, 2024 – February 22, 2026 Peritoneal Carcinomatosis: The Good, the Bad, and the Ugly Jeremiah 'Jig' Deneve, DO, FACS Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis. |
Advanced Practice Provider NCPD/CNE Available February 20, 2024 – February 19, 2026 CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities Megan McElfresh, PA-C Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects. |
Advanced Practice Provider NCPD/CNE Available January 22, 2024 – January 21, 2026 Lung Cancer Screening Essentials Jason Long, MD, MPH Kim Shoenbill, MD, PhD, MS Michelle Ottersbach, MS, DNP, RN, CNL, CRCR This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients. |
Advanced Practice Provider NCPD/CNE Available January 4, 2024 – January 3, 2026 Oncologic Emergencies: Superior Vena Cava Syndrome, Hypercalcemia, and SIADH Allison Phillips, MPAP, MHPE, PA-C Allison Phillips, MPAP, MHPE, PA-C, will review the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH. |
Advanced Practice Provider NCPD/CNE Available September 29, 2023 – October 31, 2025 Evaluation and Treatment of Extravasation Injuries from Chemotherapeutic Agents Robyn Tolley, AGPCNP-BC Robyn Tolley, AGPCNP-BC, will identify cytotoxic vesicant and irritant drugs, evaluation of infiltration and extravasation, recommended non-pharmacologic and pharmacologic treatments, and when care should be advanced to involve plastic surgery. She will also include an evaluation of risk factors and appropriate preventive measures to reduce the risk of extravasation. |
Advanced Practice Provider NCPD/CNE Available October 2, 2023 – October 1, 2025 Developing Comprehensive Exercise Programming for People Affected by Cancer Carly Bailey, MA Attendees will learn about the benefits of exercise during and after cancer treatment, designing programs that provide maximum benefits, and how to engage patients in increasing their physical activity during and after treatment. |
Advanced Practice Provider NCPD/CNE Available October 2, 2023 – October 1, 2025 Overview of Clinical Trials for the APP Clarissa Urban, PA-C Clarissa Urban, PA-C, will cover the basics of clinical trials for an APP. She will highlight the different phases of trials, the clinical trial team, and documents pertaining to trials. In addition, she will focus on phase 1 clinical trials along with diversity in trial participation. |
Advanced Practice Provider NCPD/CNE Available May 30, 2023 – May 29, 2025 Oncologic Emergencies, A Deeper Dive: Neutropenic Fever, Tumor Lysis Syndrome, and Cord Compression Laura Blanchard, MPAP, PA-C Taking a deeper dive into the most common oncologic emergencies facing oncology patients. We will discuss the clinical manifestations, diagnosis, treatment, and prevention of Neutropenic Fever, Tumor Lysis Syndrome, and Cord Compression. These topics are good refreshers for APPs practicing in primary care, urgent, emergency medicine, hematology/oncology, and inpatient medicine. |
Advanced Practice Provider NCPD/CNE Available May 10, 2023 – May 9, 2025 What Is Cancer Rehabilitation and How Can it Help My Patients? Sasha E. Knowlton, MD Sasha E. Knowlton, MD, will present an introduction to cancer rehabilitation, including details as to why function is important in cancer patients. Patients with cancer are living longer as a result of improved surveillance and treatment interventions. However, cancer survivors often develop functional impairments that can significantly affect their quality of life and independence. Dr. Knowlton will review common diagnoses and treatments in the field of cancer rehabilitation. She will also provide an overview of how cancer rehabilitation can help patients before and during treatment and into survivorship. |
Advanced Practice Provider NCPD/CNE Available April 10, 2023 – April 9, 2025 Oral Chemotherapy: Prescribing, Monitoring, and Safety Aimee Faso, PharmD, BCOP, CPP Oral chemotherapy has shifted the care of oncology patients from infusion clinics to patients' homes. This shift in care requires healthcare providers to not only manage patients differently but for patients to take on additional responsibilities. Aimee Faso, PharmD, BCOP, CPP, will address the issues related to the safe use of oral chemotherapy in oncology patients. |
Advanced Practice Provider NCPD/CNE Available February 20, 2023 – February 19, 2025 The Value of Integrative Medicine in Oncology Care Denise Spector, PhD, MPH, ANP, E-RYT Denise Spector, PhD, MPH, ANP, RYT, will provide an overview of integrative oncology which includes evidence-based strategies for helping to mitigatecommon cancer symptoms and cancer treatment-related side effects, as well as strategies that may improve one's overall healthand well-being along the cancer care continuum. |
Advanced Practice Provider NCPD/CNE Available January 13, 2023 – January 12, 2025 GVHD: An Overview of Graft vs Host Disease Post Hematopoietic Stem Cell Transplant Megan McElfresh, PA-C Megan McElfresh, PA-C, will provide an overview of the pathophysiology, diagnosis, prevention, and treatment of graft vs host disease post hematopoietic stem cell transplant. |